SINOPHARM GRP CO. H YC 1 earnings per share and revenue

X2S earnings per share for the last semiannual are 0.14 EUR whereas the estimation was 0.19 EUR which accounts for -24.11% surprise. Company revenue for the same period amounts to 38.34 B EUR despite the estimated figure of 39.08 B EUR. Estimated earnings per share for the next semiannual are 0.15 EUR, and revenue is expected to reach 38.58 B EUR. Also watch annual changes over time to get a bigger picture of X2S earnings per share and revenue dynamics.